EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND

BOSTON, Sept. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation EW announced results from CLASP IID, the first randomized controlled trial tha

Related Keywords

Boston , Massachusetts , United States , Canada , Philippe Genereux , Firas Zahr , Konstantinosp Koulogiannis , Megan Coylewright , Paula Grayburn , Jacobm Mishell , Bernardj Zovighian , Raj Makkar , Edwards Lifesciences , Lindad Gillam , Instagram , Linkedin , Twitter , Exchange Commission , Youtube , Securities Exchange , Edwards Lifesciences Corporation , Facebook , Cardiovascular Research Foundation , Transcatheter Cardiovascular Therapeutics , Scott Lim , Advanced Heart Valve Center , Virginia Health System , Prospective Registry , Transcatheter Edge To Repair , Complex Mitral Valve Anatomy , Late Breaking Presenter , Dive Session , Ralph Stephan , Bioprosthetic Valve Fracture , Patients Undergoing Valve , Failed Surgical Valves Using , Ultra Valves , Insights From Real World Data , Life After Aortic Valve Replacement , Edge To Repair , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports ,